Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 9041-9050 Newer>

Chemistry World February 24, 2015 Phillip Broadwith	B-MS bolsters immuno-oncology with pair of deals In a bid to bolster its pipeline of immuno-oncology drugs, Bristol-Myers Squibb has agreed to buy US biotech firm Flexus Biosciences in a deal worth up to $1.25 billion
Chemistry World February 23, 2015 Phillip Broadwith	Valeant to buy Salix for $14.5bn Serial acquirer Valeant has agreed to buy gastroenterology specialist Salix Pharmaceuticals for $14.5 billion
Chemistry World February 23, 2015 Phillip Broadwith	Europe approves stem cell therapy A stem cell treatment for severe cornea damage has been granted conditional approval by the European commission.
Fast Company David Lumb	The FDA Just OK'd 23AndMe To Test For One Syndrome The FDA just gave consumer genetics testing company 23AndMe permission to sell tests for Bloom syndrome -- a disease associated with shortened height and an increased cancer risk.
Fast Company March 2015 Julie Makinen	Apricot Forest Fixes What Ails Chinese Health Care Apricot Forest offers a suite of three apps that aim to fix some of the core inefficiencies in China's medical system. Twenty-five percent of China's 2.5 million doctors now use at least one of the apps, as do about 2,000 new physicians every day.
Chemistry World February 19, 2015 Andrew Turley	Hepatitis C drug patent challenged in Europe A French healthcare campaign group has launched a legal challenge to the patent covering Sovaldi (sofosbuvir), the blockbuster hepatitis C virus drug marketed by Gilead.
Fast Company March 2015 J.J. McCorvey	How Drug Company Gilead Outpaces Its Competitors -- And Common Diseases Over the past few years, Gilead has ushered through four effective new treatments for HIV alone.
Chemistry World February 16, 2015 Phillip Broadwith	Teva wins generic esomeprazole race The copycat version will be marketed by Ivax Pharmaceuticals, a subsidiary of Israeli generic behemoth Teva.
Chemistry World February 16, 2015 Phillip Broadwith	US approves internal tissue glue TissuGlu from Cohera Medical is already approved in Europe, but is the first internal adhesive to be approved in the US.
Chemistry World February 12, 2015 Rebecca Trager	Hospira buyout is a shot in the arm for Pfizer's biosimilars Pfizer said in a statement that its acquisition of Hospira will create 'a leading global sterile injectables business.
<Older 9041-9050 Newer> Return to current articles.